Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan

Active, not recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

December 22, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Lower-risk Myelodysplastic Syndromes

Interventions

PROCEDURE

Red blood cell transfusion

≥2 units of red blood cell transfusion

PROCEDURE

Red blood cell transfusion

0 units or \<2 units of red blood cell transfusion

Trial Locations (1)

Mebix, Inc, Tokyo